Stemregen

Austin, Texas

Classification

Private

Financials

Revenue & Profit

Revenue

Valuation

Valuation

Ratios

Revenue / EBITDA
$123 MM
Valuation / Revenue
$123 MM
Valuation / Employees
$123 MM
EBITDA / Revenue
$123 MM
1-Year CAGR (Revenue)
03
3-Year CAGR (Revenue)
11
1-Year CAGR (Employees)
19
3-Year CAGR (Employees)
96

People

Employee Figures

Employees

Key Executives

NameTitleSocialsEmailPhone
John DoeEmployee
--
Jane DoeEmployee
John DoeEmployee
John DoeEmployee

401K

Total Active Participants
1234
No. Participants with Account Balances
56789
Total Liabilities Start of Year
1234
Total Assets Start of Year
56789

Deals

M&A2024-03-15Completed

Seller

Founders Group

Investor Sponsors

NorthBridge PE

Deal Amount

$120M

Target Company Valuation

$1.20 MM

Techniques

Acquisition of Assets, Taken Private

Stake Tags

100%

Is PE deal

Yes

Is deal PE backed

Yes

Total Acquired

100%

Secondary Transaction2023-09-01Canceled

Target

BrightHealth Technologies

Seller

Early Investors Consortium

Investor Sponsors

--

Deal Amount

Undisclosed

Target Company Valuation

NaN

Techniques

Secondary Sale, Management Buy-out (MBO)

Stake Tags

Majority

Is PE deal

No

Is deal PE backed

Yes

Total Acquired

65%

Funding

About

About

Stemregen is a biotechnology and nutraceutical company based in Austin, Texas, specializing in natural supplements designed to support the body's innate regenerative capacity. Founded by stem cell scientist Christian Drapeau, the company focuses on developing plant-based formulations that stimulate the release and circulation of an individual's own stem cells to promote cellular repair and rejuvenation. Its flagship product, STEMREGEN®, is formulated from a blend of botanical ingredients clinically studied for their role in stem cell mobilization and overall wellness enhancement. Through continuous research, scientific validation, and partnerships with health and wellness distributors worldwide, Stemregen aims to make regenerative health accessible through safe, natural, and effective solutions that complement the body's self-healing processes. Products and Services: STEMREGEN Release - The company's primary product, designed to naturally increase the number of circulating stem cells from the bone marrow to support tissue repair and regeneration. STEMREGEN Signal - A supplement formulated to enhance intercellular communication and modulate inflammation, helping stem cells function more effectively once mobilized. STEMREGEN Mobilize - A product developed to improve blood flow and microcirculation, supporting efficient stem cell delivery to tissues. Stem Cell Support Protocols - Comprehensive wellness programs that combine multiple STEMREGEN® products into synergistic regimens for optimal regenerative results. Research and Education - Ongoing scientific research and publication of studies related to stem cell science, supplement efficacy, and regenerative wellness. Distribution and Partnership Programs - Collaboration with global distributors, health practitioners, and wellness centers to expand product reach and promote education on natural stem cell enhancement.

Keywords

Keywords

Classified

Private